Commonwealth Retirement Investments LLC Invests $536,000 in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Commonwealth Retirement Investments LLC acquired a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 8,157 shares of the company’s stock, valued at approximately $536,000. Commonwealth Retirement Investments LLC owned approximately 0.08% of iShares U.S. Pharmaceuticals ETF at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the company. US Bancorp DE raised its position in iShares U.S. Pharmaceuticals ETF by 137.0% in the third quarter. US Bancorp DE now owns 384 shares of the company’s stock valued at $27,000 after purchasing an additional 222 shares during the period. Assetmark Inc. grew its stake in iShares U.S. Pharmaceuticals ETF by 100.0% during the 3rd quarter. Assetmark Inc. now owns 432 shares of the company’s stock valued at $31,000 after purchasing an additional 216 shares in the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of iShares U.S. Pharmaceuticals ETF in the fourth quarter worth $42,000. Allworth Financial LP increased its position in shares of iShares U.S. Pharmaceuticals ETF by 9.4% in the 3rd quarter. Allworth Financial LP now owns 1,853 shares of the company’s stock worth $131,000 after purchasing an additional 159 shares during the last quarter. Finally, EP Wealth Advisors LLC bought a new stake in iShares U.S. Pharmaceuticals ETF in the third quarter valued at about $157,000.

iShares U.S. Pharmaceuticals ETF Trading Up 0.7 %

Shares of NYSEARCA IHE opened at $72.01 on Tuesday. The company has a market capitalization of $727.30 million, a price-to-earnings ratio of 6.49 and a beta of 0.58. iShares U.S. Pharmaceuticals ETF has a twelve month low of $62.67 and a twelve month high of $72.94. The business has a 50 day simple moving average of $67.90 and a 200-day simple moving average of $69.30.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.